Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "neoplasm" wg kryterium: Temat


Tytuł:
Screening colonoscopy tests in acromegaly patients – authors’ observations
Autorzy:
Malicka, Joanna
Kurowska, Maria
Dudzińska, Marta
Smoleń, Agata
Oszywa-Chabros, Anna
Tarach, Jerzy
Powiązania:
https://bibliotekanauki.pl/articles/552976.pdf
Data publikacji:
2016
Wydawca:
Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
Tematy:
acromegaly
colonoscopy
colon neoplasm.
Źródło:
Family Medicine & Primary Care Review; 2016, 3; 286-290
1734-3402
Pojawia się w:
Family Medicine & Primary Care Review
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Malignant thymoma – the most common neoplasm in goats
Autorzy:
Szaluś-Jordanow, O.
Czopowicz, M.
Witkowski, L.
Mickiewicz, M.
Moroz, A.
Kaba, J.
Sapierzyński, R.
Bonecka, J.
Jońska, I.
Garncarz, M.
Kwiatkowska, M.
Chutorański, D.
Szołkowska, M.
Frymus, T.
Powiązania:
https://bibliotekanauki.pl/articles/2087485.pdf
Data publikacji:
2019
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
goats
thymus
tumor
neoplasm
Źródło:
Polish Journal of Veterinary Sciences; 2019, 3; 475-480
1505-1773
Pojawia się w:
Polish Journal of Veterinary Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Laryngeal tumour of neurogenetic origin – case report and review of the literature
Autorzy:
Majszyk, Daniel
Krawczyk, Przemysław
Kloc, Michał
Rytel, Adam
Osuch-Wójcikiewicz, Ewa
Niemczyk, Kazimierz
Powiązania:
https://bibliotekanauki.pl/articles/1399656.pdf
Data publikacji:
2019
Wydawca:
Index Copernicus International
Tematy:
benign neoplasm
hoarseness
larynx
schwannoma
Opis:
Schwann cell tumours are a rare group of benign neoplasms that origin form peripheral nerves. 0.1%–1.5% develops in the larynx causing hoarseness, difficulty swallowing and dyspnoea. The treatment of choice is surgical resection of the tumour during open type surgery or endoscopic procedure. The chosen surgical technique depends on tumour location, size observed in clinical examination and imaging. Also, clinical manifestation of the disease is included in the decision-making process.
Źródło:
Polski Przegląd Otorynolaryngologiczny; 2019, 8, 3; 35-39
2084-5308
2300-7338
Pojawia się w:
Polski Przegląd Otorynolaryngologiczny
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Pancreatic cysts or pancreatic cystic neoplasms? An analysis of 145 cases
Autorzy:
Wlaźlak, Michał
Oleśna, Aleksandra
Danilewicz, Marian
Strzelczyk, Janusz
Powiązania:
https://bibliotekanauki.pl/articles/1392895.pdf
Data publikacji:
2018
Wydawca:
Index Copernicus International
Tematy:
pancreas
cyst
neoplasm
surgery
cancer
Opis:
Introduction: Detection of the frequency of pancreatic cystic lesions has increased in the recent years. The majority are pseudocysts, the remaining cysts are mainly neoplasms. Proven risk of malignancy affects intraductal papillary mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN). The aim of this study was to analyze clinical data of patients with pancreatic cysts or pancreatic cystic neoplasms on operate at Department of General and Transplant Surgery in the Barlicki Hospital in Lodz. Material and methods: In 2007-2016, there were 145 patients operated on at the Department of General and Transplant Surgery in Barlicki Hospital in Lodz, due to pancreatic cystic lesion. The type of operation, histopathological diagnosis and basic demographic data were analyzed. Results: Non-neoplastic cyst (mainly pseudocysts) was found in 66.9% of patients, neoplasms were detected in 33.1%. The mean age was significantly higher in patients with neoplasm than without neoplasm (57.06 years vs. 50.88 years, p=0.009). Neoplastic cyst occurred more frequently in women (68.75% of women, 31.25% of men, p=0.001). Malignant tumor was found in 14.58% of neoplasms cases and in 4.83% of all pancreatic cystic lesions. Conclusions: According to the analyzed material, there is a significant risk of malignancy in patients with pancreatic cyst. Neoplastic cysts are more common in women. Discussion: Pancreatic cystic tumors are treated mainly by resections of pancreas. In case of benign lesions with low risk of malignancy, there are less extensive operations performed, such as enucleations of lesions. There are no guidelines that could be used satisfactorily in follow up of patients with pancreatic cysts.
Źródło:
Polish Journal of Surgery; 2018, 90, 5; 22-26
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Ultrasound Elastography in Clinical Diagnostics and in Scientific Research on Muscles
Autorzy:
Rosicka, Katarzyna
Arlet, Jarosław
Bukowska, Dorota
Mierzejewska-Krzyżowska, Barbara
Powiązania:
https://bibliotekanauki.pl/articles/1030765.pdf
Data publikacji:
2019
Wydawca:
Uniwersytet Szczeciński. Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
Tematy:
diagnostic imaging
neoplasm
skeletal muscles
stiffness
Opis:
Ultrasound elastography is a revolutionary medical imaging technique, enabling a quantitative and qualitative evaluation of tissue stiffness. This paper presents, based on published evidence, a wide range of possibilities for this method in clinical trials and scientific research. The use of dynamic elastography avoids the undesired influence of force applied to the tissue by the elastograph probe on the information content of the obtained image. In clinical practice, elastography is used to identify and examine the pathological condition of soft tissues (including cancer lesions and tendonitis) and to diagnose neuromuscular diseases. It is also used in scientific investigations as a non-invasive method to study the structure of skeletal muscle, including muscle thickness, fiber length and pennation angle using standard ultrasonography mode; it is also possible to obtain information about physical properties such as stiffness. Ultrasound elastography could also be a useful tool for physiotherapists monitoring the rehabilitation process. Based on the results of these studies, advances in elastographic imaging technology, and progress in biomedical diagnostic methods, elastography is expected to become a common method used in clinical diagnostics and scientific research.
Źródło:
Central European Journal of Sport Sciences and Medicine; 2019, 27, 3; 75-82
2300-9705
2353-2807
Pojawia się w:
Central European Journal of Sport Sciences and Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
An uncommon breast lump with the diagnosis of schwannoma
Autorzy:
Shiryazdi, Seyed Mostafa
Safi Dahaj, Farzan
Alamdar Yazdi, Arezoo
Shishehbor, Fatemeh
Powiązania:
https://bibliotekanauki.pl/articles/1391894.pdf
Data publikacji:
2020
Wydawca:
Index Copernicus International
Tematy:
breast
neoplasm
palpable breast mass
schwannoma
Opis:
Introduction: Schwannoma (neurilemmoma) is a kind of a slow-growing, benign, and heterogeneous neoplasm originating from Schwann cells. Schwannoma has a predilection for the head, neck, and extremities. However, it can occur in the breast dermis, deep breast parenchyma, and axillary soft tissue. Case report: In this study, a 51-year-old woman is reported with a breast mass suspected of malignancy, who was diagnosed with schwannoma by a pathologist after surgery. In cases with palpable breast masses, Schwannoma should be considered as a part of differential diagnosis. In spite of various imaging modalities used in the diagnostics of breast lesions, excisional or core needle biopsy is suggested for the definitive diagnosis of schwannoma.
Źródło:
Polish Journal of Surgery; 2020, 92, 5; 60-62
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Diagnosis and therapy of neuroendocrine neoplasms of the gastrointestinal tract
Autorzy:
Deptała, Andrzej
Czerw, Aleksandra
Powiązania:
https://bibliotekanauki.pl/articles/551709.pdf
Data publikacji:
2016
Wydawca:
Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
Tematy:
neuroendocrine neoplasm
overview
symptoms
diagnosis
treatment.
Źródło:
Family Medicine & Primary Care Review; 2016, 3; 377-381
1734-3402
Pojawia się w:
Family Medicine & Primary Care Review
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Lipomas – a health condition that cannot be ignored
Autorzy:
Sitarz, Robert
Skierucha, Małgorzata
Jazienicki, Mieczysław
Kurylcio, Andrzej
Wierzbicki, Ryszard
Maciejewski, Ryszard
Polkowski, Wojciech
Powiązania:
https://bibliotekanauki.pl/articles/552891.pdf
Data publikacji:
2016
Wydawca:
Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
Tematy:
lipoma
lipomatosis
soft tissue neoplasm
general practice.
Źródło:
Family Medicine & Primary Care Review; 2016, 4; 473-476
1734-3402
Pojawia się w:
Family Medicine & Primary Care Review
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Limitations in cardiovascular fitness and rehabilitation of oncologically treated patients
Ograniczenia wydolności układu krąŜenia a rehabilitacja pacjentów leczonych onkologicznie
Autorzy:
Hojan, Katarzyna
Powiązania:
https://bibliotekanauki.pl/articles/1963092.pdf
Data publikacji:
2012
Wydawca:
Akademia Wychowania Fizycznego im. Bronisława Czecha w Krakowie
Tematy:
neoplasm
cardiotoxicity
Physical activity
cardio-pulmonary fitness
Opis:
Introduction: Applying increasingly modern forms of cancer treatment contributes to the higher survival of patients with neoplasm. Nevertheless, every single element of such a treatment, no matter how effective, brings some risk of cardiovascular complications.Objective: The study objective was a review of the clinical research analyzing cardiovascular complications resulting from various forms of oncological treatment and the use of rehabilitation in these patients.Material: The study presents contemporary forms of cancer treatment which may cause negative cardiovascular symptoms.Results: Due to their negative influence on the cardiovascular system oncological drugs can be divided into those: causing heart muscle mass loss, arrhythmia, with a cardio depressive effect, hypertension, heart ischemia as well as those enhancing thrombo-embolic disorders. The cardiotoxicity of oncological treatment is very frequent in patients after combination therapy (using chemotherapy or/and radiotherapy) or with coexisting heart disease. According to the heart failure classification every patient after chemotherapy or/and radiotherapy has a higher risk of its development. Thus it is important to know the type of treatment, its dosages, the time from initiation to the treatment completion, so that the rehabilitation program for this group of patients based on exercise is applied through correct medically supervised physical activities.Conclusions: The oncological benefit of therapy is much higher than the possible cardiological risk but, keeping the patient’s wellbeing in mind, an optimal cardiac diagnostic is necessary so as rehabilitation is based on individual cardiac fitness. In patients with cancer, special attention should be paid to the assessment of the cardio-respiratory endurance rates before rehabilitation and the choice of physical activity, sporting discipline made for this group of patients.
Wstęp: Zastosowanie co raz nowszych form terapii w leczeniu onkologicznym poprawia skutecznie przeżycie chorych na nowotwory. Nadal jednak każdy element tej terapii, jakkolwiek bardzo skuteczny, niesie ryzyko powikłań ze strony układu krążenia. Cel: Celem badań było przedstawienie przeglądu badań klinicznych oceniających powikłania w układzie sercowo-naczyniowym wynikające z zastosowania różnych form leczenia onkologicznego oraz rehabilitacji w tej grupie pacjentów. Materiał: W pracy przedstawiono współczesne leczenie nowotworów, które może powodować objawy niepożądane z zakresu układu sercowo-naczyniowego. Wyniki: Leki onkologiczne ze względu na negatywny wpływ na układ sercowo-naczyniowy podzielono na: powodujące utratę masy mięśnia sercowego, wywołujące zaburzenia rytmu i przewodzenia, o działaniu kardiodepresyjnym, powodujące nadciśnienie, niedokrwienie mięśnia sercowego oraz sprzyjające incydentom zakrzepowo-zatorowym. Kardiotoksyczność terapii onkologicznej jest szczególnie wyrażona u pacjentów po leczeniu skojarzonym (z zastosowaniem chemioterapii i radioterapii) lub współistniejącą chorobą serca. Zgodnie z klasyfikacją niewydolności serca kaŜdy pacjent po chemioterapii i/lub radioterapii ma zwiększone ryzyko jej rozwoju, dlatego ważna jest znajomość rodzaju stosowanego leczenia onkologicznego, jego dawek, cykli i czasu od rozpoczęcia lub zakończenia leczenia, aby program usprawniania dla tej grupy pacjentów, oparty o zastosowanie wysiłku fizycznego, był realizowany poprzez właściwą aktywność fizyczną i pod kontrolą lekarza. Wnioski: Korzyść onkologiczna terapii jest dużo wyższa niż potencjalne ryzyko kardiologiczne, ale mając na uwadze dobro pacjenta, konieczna jest optymalna diagnostyka kardiologiczna i prowadzenie rehabilitacji w zależności od określonej wydolności krążenia. U chorych leczonych onkologicznie należy ze szczególną uwagą ocenić wydolność krążeniowo-oddechową przed rozpoczęciem rehabilitacji oraz zaproponowaniem aktywności fizycznej (np. dyscypliny sportowej) w tej grupie pacjentów.
Źródło:
Medical Rehabilitation; 2012, 16(1); 19-25
1427-9622
1896-3250
Pojawia się w:
Medical Rehabilitation
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Morbidity, Mortality and Survival after Stomach Resection with or without Splenectomy – The Single Centre Observations
Autorzy:
Stojcev, Zoran
Bobowicz, Maciej
Jarząb, Michał
Pawłowska-Stojcev, Tomasz
Banasiewicz, Tomasz
Powiązania:
https://bibliotekanauki.pl/articles/1396190.pdf
Data publikacji:
2013-08-01
Wydawca:
Index Copernicus International
Tematy:
neoplasm
stomach
splenectomy
complications
lymph node excision
Opis:
Over the last decade, gastric cancer treatment has changed from extensive multiorgan resections towards less invasive approaches with limited resections and a more selective lymphadenectomy. Despite all available trials, the conclusions on the extent of necessary resections still remain debatable. The aim of the study was to assess the short term outcomes (morbidity and mortality) of a total gastrectomy depending on the simultaneous splenectomy status. Material and methods. We performed a retrospective analysis of the records of all patients treated with a curative intent using a total gastrectomy for gastric cancer between 1997 and 2003. 49 patients fulfilled the inclusion criteria. Patients were divided into two groups: S(+) gastrectomy with splenectomy group (29 patients) and S(-) total gastrectomy with spleen preservation (20 patients). Results. Survival analysis at one year showed that there was no difference in survival between the two groups (p=0.84). There were six recurrences, one in the group S(+) and five in group S(-) (p>0.05). Dissemination was observed in three patients in group S(-) (p>0.05). Other complications including infectious complications, exenteration, subileus, cardiovascular insufficiency, multiorgan failure were more frequent in the S(+) group (31% v 15%) although the difference was not significant (p=0.17). Conclusions. Splenectomy during gastrectomy for cancer has no statistically significant impact on short-term morbidity and mortality. Even though it does not show benefit in terms of 5-year overall survival rates it might be performed when needed in more advanced cases in properly selected patients (e.g. upper gastric T3/4 gastric cancer)
Źródło:
Polish Journal of Surgery; 2013, 85, 8; 433-437
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Breast fibroadenomas: a review in the light of current literature
Autorzy:
Salati, Sajad Ahmad
Powiązania:
https://bibliotekanauki.pl/articles/1391523.pdf
Data publikacji:
2021
Wydawca:
Index Copernicus International
Tematy:
adolescence
benign breast neoplasm
breast lump
fibroadenoma
observation
Opis:
Introduction: Fibroadenomas are one of the most common benign tumors of the breast in the adolescent females accounting for about 2/3rd of all the breast lumps and more than half of all the biopsied breast lesions. They come into being due to overgrowth of glandular tissue under the influence of hormonal changes that the girls undergo at the time of puberty. Due to the wide prevalence of fibroadenomas and the psychosocial morbidity associated with the finding of a breast mass, it is imperative for physicians treating adolescent patients to be thoroughly familiar and updated with this disease. Aim: The article aims at providing a brief review of the classification, presentation, diagnosis, and update on the management of breast fibroadenomas on the basis of recent literature.
Źródło:
Polish Journal of Surgery; 2021, 93, 1; 40-48
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Clinical manifestation of malignant lymphomas of the head and neck region
Autorzy:
Bojanowska-Poźniak, Katarzyna
Nurkowska, Monika
Danilewicz, Marian
Pietruszewska, Wioletta
Powiązania:
https://bibliotekanauki.pl/articles/1398500.pdf
Data publikacji:
2017
Wydawca:
Index Copernicus International
Tematy:
malignant lymphoma
head and neck neoplasm
extranodal lymphoma
Opis:
Introduction: Malignant lymphoma (ML) is a neoplasm caused by clonal expansion of undifferentiated B, T and NK-lymphoid cells. WHO classification divides lymphomas into two main types, i.e. Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL), with numerous subtypes. The majority of MLs are localized in lymph nodes, but extranodal locations are also possible. MLs represent approximately 3-5% of all malignant neoplasms in Poland, but their incidence has been increasing in recent years, especially in young patients. The objective of the study was to evaluate clinical manifestations and diagnostic process in patients with malignant lymphomas of the head and neck region as diagnosed in the Department of Otorhinolaryngology of the Medical University of Lodz in years 2013-2017. Material and method: 30 patients diagnosed with malignant lymphomas of the head and neck region at the Departbadament of Otorhinolaryngology of the Medical University of Lodz in 2013-2017. Results: The study group consisted of 8 cases of nodal lymphomas and 22 cases of extranodal lymphomas. In 29 cases B-cell lymphomas were diagnosed. The most common symptoms included lymphadenopathy or neck tumor. Other symptoms were associated with the location of tumors in particular body organs. The diagnosis was based on histopathological examination of biopsy (needle or surgical) samples. Conclusion: Malignant lymphomas should be taken into account during differential diagnosis of the tumor or lymphadenopathy of the neck. The diagnosis is difficult because of the nonspecificity of symptoms and the need for interdisciplinary cooperation of many specialists.
Źródło:
Polish Journal of Otolaryngology; 2017, 71, 6; 14-21
0030-6657
2300-8423
Pojawia się w:
Polish Journal of Otolaryngology
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Association between clinical stage of oral cancer and expression of immunohistochemical markers
Autorzy:
Świątkowski, Wojciech
Rahnama, Mansur
Tomaszewski, Tomasz
Bigas, Mariola
Świątkowska, Agnieszka
Łobacz, Michał
Wallner, Jan
Powiązania:
https://bibliotekanauki.pl/articles/1393147.pdf
Data publikacji:
2017
Wydawca:
Index Copernicus International
Tematy:
oral cancer
neoplasm markers
squamous cell carcinoma
proliferation markers
Opis:
Aim: The aim of this study is to demonstrate the possible correlation between the expression of examined protein markers - p53, EGFR, PCNA, p44/42 in the mass of the tumor and the clinical stage of disease. Material: 48 patients of the Department and Clinic of Oral and Maxillofacial Surgery, Lublin diagnosed with oral cancer. The control group consisted of 10 patients diagnosed with leukoplakia lesions in the oral cavity. The methods: Immunohistochemical analysis using the detection system DAKO K5007 Cat - Dako REAL ™ Detection System, Peroxidase DAB +, Rabbit / Mouse. Results: Based upon the statistical results, significant correlation between p53 protein and tumor staging; however, a correlation between the level of expression of EGFR, p44/42, PCNA and staging was not likewise revealed. Conclusions: Looking for oral squamous cell carcinoma markers remains an actual issue. Identification of specific markers of oral cancer could be used in screening the population, determining prognosis and response to treatment.
Źródło:
Polish Journal of Surgery; 2017, 89, 6; 17-22
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The current state of knowledge on small cell and non-small cell lung cancer and the position of durvalumab immunotherapy in lung cancer treatment
Autorzy:
Poboży, Kamil
Domańska, Julia
Domański, Paweł
Powiązania:
https://bibliotekanauki.pl/articles/3200762.pdf
Data publikacji:
2023-01-24
Wydawca:
Medical Education
Tematy:
PD-L1
immunotherapy
durvalumab
neoplasm
oncology
SCLC
NSCLC
Opis:
Lung cancer is the second most frequently diagnosed cancer and the leading cause of cancer-related deaths in the world. These statistics make lung cancer one of the most important targets for modern medicine. The identification of multiple risk factors, including tobacco smoking, has been fundamental in understanding the disease. Late-stage detection is a significant contributor to the high mortality rate of lung cancer. Nonetheless, the role of screening is still debatable. The selection of therapy is primarily based on distinguishing between small-cell and non-small cell lung cancer. Despite the major differences in treatment, in both types in specific situations the treatment involves durvalumab – a monoclonal antibody targeting the programmed cell death ligand 1 molecule, which is often present on tumor cells and protects them against the patient’s immune system. The efficacy of durvalumab has been demonstrated in two randomized, multicenter clinical trials. The aim of this study is to summarize the current state of knowledge about lung cancer and durvalumab. Despite the current 5-year survival rate of 19% in lung cancer, the development of immunotherapeutics such as durvalumab may be the key to improving the unfavorable prognosis of lung cancer in the future.
Źródło:
OncoReview; 2022, 12, 4; 75-82
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Patient with disseminated malignant tumor of the pancreas. Application of liposomal irinotecan as a new option of palliative treatment
Autorzy:
Galińska, Bogumiła
Becht, Rafał
Powiązania:
https://bibliotekanauki.pl/articles/2047218.pdf
Data publikacji:
2021-07-12
Wydawca:
Medical Education
Tematy:
liposomal irinotecan
malignant neoplasm of the pancreas
pancreatic cancer
Opis:
In palliative treatment of pancreatic neoplasms, chemotherapy regimens with gemcitabine, nab-paclitaxel, oxaliplatin, irinotecan, 5-fluorouracil or combinations of these drugs are used. The registration of liposomal irinotecan in the treatment of stage IV disease in patients with progression after gemcitabine creates new options for the treatment choice. The described case concerns a relatively young patient in whom the use of liposomal irinotecan in the registration indication turned out to be a safe and well-tolerated treatment.
Źródło:
OncoReview; 2021, 11, 3; 73-76
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies